Regulatory Hurdles Put LivePerson Merger Timeline and Benefits at Risk

Liveperson (LPSN) has disclosed a new risk, in the Regulation category.

LivePerson faces uncertainty because the Merger cannot close until multiple regulatory approvals, consents and non‑objection decisions are obtained in relevant jurisdictions, and these may be delayed or denied outright. Even if approvals are granted, regulators could impose divestitures, operating restrictions or other conditions that reduce the anticipated strategic and financial benefits of the Merger or jeopardize its completion.

Overall, Wall Street has a Hold consensus rating on LPSN stock based on 2 Holds.

To learn more about Liveperson’s risk factors, click here.